BriaCell closes $15M public offering of 12M units at $1.25/unit

BriaCell Therapeutics Corp.

Gross proceeds of $15M before fees; 12,000,000 units sold at $1.25 per unit.
Each unit comprises one common share (or pre-funded warrant at $0.001) and one warrant exercisable at $1.50 for five years.
ThinkEquity acted as sole placement agent; cash fee of 7.5% of gross proceeds.
Net proceeds earmarked for working capital, general corporate purposes, and advancement of business objectives.
Relies on TSX exemption for interlisted issuers; no Canadian prospectus filed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.